首页 > 市场调查报告书 > 製药

药物开发临床实验临床开发

北美临床试验市场预测至 2028 年 - 区域分析 - 按研究设计、阶段和适应症

市场调查报告书

商品编码

1402477

北美临床试验市场预测至 2028 年 - 区域分析 - 按研究设计、阶段和适应症

North America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design, Phase, and Indication

出版日期: 2023年10月26日 | 出版商:

The Insight Partners | 英文 132 Pages | 订单完成后即时交付

价格

简介目录图表

北美临床试验市场预计将从2022年的273.2228亿美元成长到2028年的3,681,815万美元。预计2022年至2028年CAGR为5.1%。

医药产业的蓬勃发展和医药产业研发活动的增加推动北美临床试验市场

製药业是全球研发最密集的产业之一。随着製药公司热衷于确保研发实现其预期目标，药品的价值变得越来越重要。在过去十年中，每年批准的新药数量也有所增加。我们正在努力提高满足患者需求的有效性和效率。美国是研发投资的领先国家，在过去十年中生产了世界上一半以上的新分子。美国占 2014-2019 年新上市新药销售额的 62.3%。研发是製药公司业务的重要组成部分，因为它使製药公司能够为各种治疗应用开发出具有巨大医疗和商业潜力的新分子。

研发支出用于发现、检验和生产新产品；预付款；改善现有成果；并在推出前证明产品功效和法规合规性。研发投资依临床试验的需要和要求而有所不同。成本包括材料、使用的用品和工资，以及开发品质控制的成本。

北美临床试验市场概况

北美临床试验市场分为美国、加拿大和墨西哥。美国是最大且成长最快的临床试验市场。该地区的市场成长归功于美国作为领先的临床研究目的地以及公司为临床试验应用提供的创新服务。

美国已成为领先的临床研究目的地。近一半的临床试验是在美国进行的。此外，由于成熟的医疗基础设施、快速的审批时间表、有利的监管框架以及全球公认的临床试验产生资料，大多数製药研究公司更愿意在美国进行临床试验。世界卫生组织 (WHO) 报告指出，美国 2021 年登记的临床试验数量最多（157,618 项）。

北美临床试验市场收入及 2028 年预测（百万美元）

北美临床试验市场细分

北美临床试验市场分为阶段、研究设计、适应症和国家。

根据阶段，北美临床试验市场分为 I 期、II 期、III 期和 IV 期。 2022 年，III 期临床试验市占率占北美最大市场。

根据研究设计，北美临床试验市场分为介入性、观察性和扩展性。 2022 年，介入性细分市场占据北美最大的临床试验市场。

根据适应症，北美临床试验市场分为自体免疫/发炎、疼痛管理、肿瘤、中枢神经系统疾病、糖尿病、肥胖、心血管等。 2022 年，肿瘤学领域占据北美最大的临床试验市场。

依国家划分，北美临床试验市场分为美国、加拿大和墨西哥。 2022年，美国在北美临床试验市场份额中占据主导地位。

Charles River Laboratories International Inc、ICON Plc、IQVIA Holdings Inc、IXICO Plc、Laboratory Corp of America Holdings、Parexel International Corp、SGS SA、Syneos Health Inc、Thermo Fisher Scientific Inc 和 WuXi AppTec Co Ltd. 都是领先公司业务遍及北美北美临床试验市场。

The pharmaceutical industry is one of the most R&D-intensive industries globally. The value of medicines is becoming increasingly important as pharmaceutical companies are keen to ensure that R&D achieves their intended goal. Over the last decade, the number of new drugs approved yearly has also increased. Efforts are being made to achieve greater effectiveness and efficiency in fulfilling patients' needs. The US is a leading country in R&D investments, producing over half of the world's new molecules in the past decade. The US accounted for 62.3% of sales of new medicines launched during 2014-2019. R&D is a significant and essential part of the business of pharmaceutical companies as it enables them to come up with new molecules for various therapeutic applications with significant medical and commercial potential.

R&D expenditure is done to discover, examine, and produce new products; upfront payments; improve existing outcomes; and demonstrate product efficacy and regulatory compliance before launch. The R&D investments differ as per the need and demand for clinical trials. The cost includes materials, supplies used, and salaries, along with the cost of developing quality control.

North America Clinical Trials Market Overview

The North America clinical trials market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for clinical trials. The market growth in the region is accredited to the US emerging as a leading clinical research destination and the innovative services offered by companies for applications in clinical trials.

The US has emerged as a leading clinical research destination. Nearly half of the total clinical trials are conducted in the US. Additionally, most pharma research companies prefer to perform clinical trials in the US owing to established medical infrastructure, fast approval timelines, a favorable regulatory framework, and accepted clinical trial generated data globally. A World Health Organization (WHO) report states that the US registered the highest number of clinical trials (157,618) in 2021.

North America clinical Trials Market Revenue and Forecast to 2028 (US$ Million)

North America Clinical Trials Market Segmentation

The North America clinical trials market is segmented into phase, study design, indication, and country.

Based on phase, the North America clinical trials market is segmented into phase I, phase II, phase III, and phase IV. The phase III segment registered the largest North America clinical trials market share in 2022.

Based on study design, the North America clinical trials market is segmented into interventional, observational, and expanded access. The interventional segment held the largest North America clinical trials market share in 2022.

Based on Indication, the North America clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, CNS condition, diabetes, obesity, cardiovascular, and others. The oncology segment held the largest North America clinical trials market share in 2022.

Based on country, the North America clinical trials market has been categorized into the US, Canada, and Mexico. The US dominated the North America clinical trials market share in 2022.

Charles River Laboratories International Inc, ICON Plc, IQVIA Holdings Inc, IXICO Plc, Laboratory Corp of America Holdings, Parexel International Corp, SGS SA, Syneos Health Inc, Thermo Fisher Scientific Inc, and WuXi AppTec Co Ltd. are some of the leading companies operating in the North America clinical trials market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America clinical trials market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America clinical trials market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the clinical trials market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Clinical Trials Market - By Phase
- 1.3.2 North America Clinical Trials Market - By Study Design
- 1.3.3 North America Clinical Trials Market - By Indication
- 1.3.4 North America Clinical Trials Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Clinical Trials Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
4.3 Experts Opinion

5. North America Clinical Trials Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Adoption and Outsourcing of Clinical Trials
- 5.1.2 Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry
5.2 Market Restraints
- 5.2.1 Expensive and Time-Consuming Process
5.3 Market Opportunities
- 5.3.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
5.4 Future Trends
- 5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis

6. Clinical Trials Market - North America Analysis

6.1 North America Clinical Trials Market Revenue Forecast and Analysis

7. North America Clinical Trials Market Revenue and Forecast To 2028 - by Study Design

7.1 Overview
7.2 North America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
7.3 Interventional
- 7.3.1 Overview
- 7.3.2 Interventional: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Observational
- 7.4.1 Overview
- 7.4.2 Observational: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Expanded Access
- 7.5.1 Overview
- 7.5.2 Expanded Access: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Clinical Trials Market - By Phase

8.1 Overview
8.2 North America Clinical Trials Market, by Phase, 2022 and 2028 (%)
8.3 Phase III
- 8.3.1 Overview
- 8.3.2 Phase III: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Phase II
- 8.4.1 Overview
- 8.4.2 Phase II: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Phase IV
- 8.5.1 Overview
- 8.5.2 Phase IV: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Phase I
- 8.6.1 Overview
- 8.6.2 Phase I: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Clinical Trials Market Revenue and Forecast To 2028 - Indication

9.1 Overview
9.2 North America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
9.3 Autoimmune/Inflammation
- 9.3.1 Overview
- 9.3.2 Autoimmune/Inflammation: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Pain Management
- 9.4.1 Overview
- 9.4.2 Pain Management: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Oncology
- 9.5.1 Overview
- 9.5.2 Oncology: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.6 CNS Condition
- 9.6.1 Overview
- 9.6.2 CNS Condition: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.7 Diabetes
- 9.7.1 Overview
- 9.7.2 Diabetes: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.8 Obesity
- 9.8.1 Overview
- 9.8.2 Obesity: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.9 Cardiovascular
- 9.9.1 Overview
- 9.9.2 Cardiovascular: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
9.10 Other
- 9.10.1 Overview
- 9.10.2 Other: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Clinical Trials Market - Revenue and Forecast to 2028 - Country Analysis

10.1 North America: Clinical Trials Market
- 10.1.1 Overview
- 10.1.2 North America: Clinical Trials Market, by Country, 2022& 2028 (%)
  - 10.1.2.1 US: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 US: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.1.3 US: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.1.4 US: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.1.5 US: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.2 Canada: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Canada: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.2.3 Canada: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.2.4 Canada: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.2.5 Canada: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)
  - 10.1.2.3 Mexico: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 Mexico: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.2.3.3 Mexico: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)
    - 10.1.2.3.4 Mexico: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)
    - 10.1.2.3.5 Mexico: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 IQVIA Holdings Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Parexel International Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 IXICO Plc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 ICON Plc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 WuXi AppTec Co Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 SGS SA
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Syneos Health Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Thermo Fisher Scientific Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Laboratory Corp of America Holdings
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. US Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 2. US Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 4. Canada: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico: Clinical Trials Market, by Phase - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Clinical Trials Market, by Study Design - Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico: Clinical Trials Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments Done by Companies
Table 11. Inorganic Developments Done by Companies
Table 12. Glossary of Terms

List Of Figures

Figure 1. North America Clinical Trials Market Segmentation
Figure 2. North America Clinical Trials Market, By Country
Figure 3. North America Clinical Trials Market Overview
Figure 4. Phase III Segment Held Largest Share of Phase Segment in North America Clinical Trials Market
Figure 5. Canada is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. North America Experts Opinion
Figure 8. Impact Analysis
Figure 9. North America Clinical Trials Market- Revenue Forecast and Analysis - 2020- 2028
Figure 10. North America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)
Figure 11. Interventional: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Observational: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Expanded Access: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Clinical Trials Market, by Phase 2022 and 2028 (%)
Figure 15. Phase III: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Phase II: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Phase IV: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Phase I: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. North America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)
Figure 20. Autoimmune/Inflammation: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Pain Management: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Oncology: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. CNS Condition: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Diabetes: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Obesity: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiovascular: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Other: North America Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America: Clinical Trials Market, by Key Country - Revenue (2022) (US$ Million)
Figure 29. North America: Clinical Trials Market, by Country, 2022 & 2028 (%)
Figure 30. US: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Canada: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Mexico: Clinical Trials Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Growth Strategies Done by the Companies in the Market, (%)